Marksans Pharma Q4 Results

  • BSE: 524404
  • NSE: MARKSANS
  • ISIN: INE750C01026
  • Sector: Biotechnology & Drugs
BSE
315.77.15 (2.32%)
Volume83.85 K
Updated: Mon 25 Nov, 2024 | 15:40:44
NSE
315.556.90 (2.24%)
Volume1.48 M
Updated: Mon 25 Nov, 2024 | 15:44:08
Today: 310.00
318.70
52-Wk: 126.05
328.35

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Marksans Pharma Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 560.01479.83-%485.98-%
    Selling/ General/ Admin Expenses Total 79.7562.19-%60.89-%
    Depreciation/ Amortization 21.0512.74-%13.94-%
    Other Operating Expenses Total 100.80101.51-%71.70-%
    Total Operating Expense 471.43415.93-%390.37-%
    Operating Income 88.5963.90-%95.60-%
    Net Income Before Taxes 100.2879.20-%104.17-%
    Net Income 78.2963.41-%81.93-%
    Diluted Normalized EPS 1.731.56-%1.85-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts